MedPath

Evaluation of Lowsonia inermis (Henna) and Zataria multiflora (Shirazi thyme) in treatment of cutaneous leishmaniasis

Phase 2
Recruiting
Conditions
Cutaneous leishmaniasis.
Cutaneous leishmaniasis
Registration Number
IRCT20150105020570N3
Lead Sponsor
Shiraz University of Medical Sciences, Shiraz, Iran.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

confirmation of CL based on positive smear
culture positive from lesion
PCR positive
Under 70 years old

Exclusion Criteria

pregnant women
mother feeding their babies
using immunodeficient drugs from three months ago
using any treatment for leishmaniasis

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Decreased inflammation, shrinkage of the wound, absence of parasite in the wound. Timepoint: 14 days,45days ,3 month. Method of measurement: Observation and measure of the lesion.
Secondary Outcome Measures
NameTimeMethod
. Timepoint: . Method of measurement: .
© Copyright 2025. All Rights Reserved by MedPath